Protection against Ebola, one of the world's deadliest viruses, can be achieved by a vaccine produced in insect cells, raising prospects for developing an effective vaccine for humans, say scientists at the Southwest Foundation for Biomedical Research (SFBR).
 
"The findings are significant in that the vaccine is not only extremely safe and effective, but it is also produced by a method already established in the pharmaceutical industry," says SFBR's Ricardo Carrion, Ph.D., one of the primary authors of the study.  "The ability to produce the vaccine efficiently is attractive in that production can be scaled up quickly in the case of an emergency and doses can be produced economically." Full Story.